|
| |
| | | 61385 | | 29.05.2012 | | Boehringer Ingelheim (Schweiz) GmbH | | | | | | | | | | | | | 60000. | | | | 06.03. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 02 | Pradaxa 110 mg | Kapseln | Capsules (Dabigatranum Etexilatum 110 mg) | B01AE07 | CI | | 03 | Pradaxa 150 mg | Kapseln | Capsules (Dabigatranum Etexilatum 150 mg) | B01AE07 | CI |
|
|
|
